The FDA has approved a new drug to treat Alzheimer's and is spanning access to the treatment. It's am antibody treatment called "Lequembi." Studies show the medication can slow the process of Alzheimer's when taken in the early stated of the Disease.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA grants full approval to new Alzheimer's drug meant to slow diseaseBREAKING: FDA grants full approval of Alzheimer’s drug Leqembi, amid concerns about its safety, cost and accessibility. The move marks the first time that a drug meant to slow the progression of the disease has been granted full regulatory approval.
Source: NBCNews - 🏆 10. / 86 Read more »
FDA Approves Promising New Alzheimer’s Drug LeqembiNot only is it the first Alzheimer’s antibody treatment to get full FDA approval, it’s also the first that will be broadly covered by Medicare.
Source: thedailybeast - 🏆 307. / 63 Read more »
FDA Approves New Drug to Slow Alzheimer's DiseaseThe FDA today approved a new therapy for early Alzheimer's disease that appears to modestly slow the progression of the disease that affects more than 6.5 million Americans.
Source: Medscape - 🏆 386. / 55 Read more »
FDA Approves New Drug to Slow Alzheimer’s DiseaseThe FDA today approved a new therapy for early Alzheimer’s disease that appears to modestly slow the progression of the disease that affects more than 6.5 million Americans.
Source: WebMD - 🏆 709. / 51 Read more »
The FDA Just Opened Up Access to a Promising New Alzheimer's DrugThe US drug regulator gave full approval to a new Alzheimer's medicine on Thursday, a move that makes it more widely available to the public through government-run health insurance for the elderly.
Source: ScienceAlert - 🏆 63. / 68 Read more »